131 related articles for article (PubMed ID: 15306129)
21. N-Ethylmaleimide sensitive factor in the cortex of subjects with schizophrenia and bipolar I disorder.
Gray L; Scarr E; Dean B
Neurosci Lett; 2006 Jan; 391(3):112-5. PubMed ID: 16165270
[TBL] [Abstract][Full Text] [Related]
22. Pick bodies in a family with presenilin-1 Alzheimer's disease.
Halliday GM; Song YJ; Lepar G; Brooks WS; Kwok JB; Kersaitis C; Gregory G; Shepherd CE; Rahimi F; Schofield PR; Kril JJ
Ann Neurol; 2005 Jan; 57(1):139-43. PubMed ID: 15622541
[TBL] [Abstract][Full Text] [Related]
23. Lysosome-associated membrane protein 1 (LAMP-1) in Alzheimer's disease.
Barrachina M; Maes T; Buesa C; Ferrer I
Neuropathol Appl Neurobiol; 2006 Oct; 32(5):505-16. PubMed ID: 16972884
[TBL] [Abstract][Full Text] [Related]
24. The expression of HMGA1a is increased in lymphoblastoid cell lines from schizophrenia patients.
Morikawa T; Manabe T; Ito Y; Yamada S; Yoshimi A; Nagai T; Ozaki N; Mayeda A
Neurochem Int; 2010; 56(6-7):736-9. PubMed ID: 20347905
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical and immunoblot analysis of gamma-aminobutyric acid B receptor in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
Ishikawa M; Mizukami K; Iwakiri M; Asada T
Neurosci Lett; 2005 Aug; 383(3):272-7. PubMed ID: 15955420
[TBL] [Abstract][Full Text] [Related]
26. Novel function of PS2V: change in conformation of tau proteins.
Nishikawa A; Manabe T; Katayama T; Kudo T; Matsuzaki S; Yanagita T; Okuda H; Bando Y; Tohyama M
Biochem Biophys Res Commun; 2004 May; 318(2):435-8. PubMed ID: 15120619
[TBL] [Abstract][Full Text] [Related]
27. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease.
Wang J; Xiong S; Xie C; Markesbery WR; Lovell MA
J Neurochem; 2005 May; 93(4):953-62. PubMed ID: 15857398
[TBL] [Abstract][Full Text] [Related]
28. Induced HMGA1a expression causes aberrant splicing of Presenilin-2 pre-mRNA in sporadic Alzheimer's disease.
Manabe T; Katayama T; Sato N; Gomi F; Hitomi J; Yanagita T; Kudo T; Honda A; Mori Y; Matsuzaki S; Imaizumi K; Mayeda A; Tohyama M
Cell Death Differ; 2003 Jun; 10(6):698-708. PubMed ID: 12761578
[TBL] [Abstract][Full Text] [Related]
29. Polymorphism of the regulatory region of the presenilin-2 gene in sporadic Alzheimer's disease: a case-control study.
Quan W; Yasuda M; Hashimoto M; Yamamoto Y; Ishii K; Kazui H; Mori E; Kakigi T; Maeda K
J Neurol Sci; 2006 Jan; 240(1-2):71-5. PubMed ID: 16233903
[TBL] [Abstract][Full Text] [Related]
30. RCAN1-1L is overexpressed in neurons of Alzheimer's disease patients.
Harris CD; Ermak G; Davies KJ
FEBS J; 2007 Apr; 274(7):1715-24. PubMed ID: 17331188
[TBL] [Abstract][Full Text] [Related]
31. mRNA expression of AMPA receptors and AMPA receptor binding proteins in the cerebral cortex of elderly schizophrenics.
Dracheva S; McGurk SR; Haroutunian V
J Neurosci Res; 2005 Mar; 79(6):868-78. PubMed ID: 15696539
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of calcium/calmodulin-dependent protein kinase IIbeta in frontal cortex in schizophrenia and depression.
Novak G; Seeman P; Tallerico T
Synapse; 2006 Jan; 59(1):61-8. PubMed ID: 16247765
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of mitogen-activated protein kinases and immediate early genes fos and jun in thalamus in schizophrenia.
Kyosseva SV
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):997-1006. PubMed ID: 15380860
[TBL] [Abstract][Full Text] [Related]
34. Identification of regulatory cis-acting elements for alternative splicing of presenilin 2 exon 5 under hypoxic stress conditions.
Higashide S; Morikawa K; Okumura M; Kondo S; Ogata M; Murakami T; Yamashita A; Kanemoto S; Manabe T; Imaizumi K
J Neurochem; 2004 Dec; 91(5):1191-8. PubMed ID: 15569262
[TBL] [Abstract][Full Text] [Related]
35. Human MIP synthase splice variants in bipolar disorder.
Shamir A; Shaltiel G; Mark S; Bersudsky Y; Belmaker RH; Agam G
Bipolar Disord; 2007 Nov; 9(7):766-71. PubMed ID: 17988368
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical and immunoblot analysis of Dopamine and cyclic AMP-regulated phosphoprotein, relative molecular mass 32,000 (DARPP-32) in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
Ishikawa M; Mizukami K; Iwakiri M; Asada T
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1177-81. PubMed ID: 17521792
[TBL] [Abstract][Full Text] [Related]
37. Expression of tau mRNA and soluble tau isoforms in affected and non-affected brain areas in Alzheimer's disease.
Boutajangout A; Boom A; Leroy K; Brion JP
FEBS Lett; 2004 Oct; 576(1-2):183-9. PubMed ID: 15474035
[TBL] [Abstract][Full Text] [Related]
38. VASE-containing N-CAM isoforms are increased in the hippocampus in bipolar disorder but not schizophrenia.
Vawter MP; Hemperly JJ; Hyde TM; Bachus SE; VanderPutten DM; Howard AL; Cannon-Spoor HE; McCoy MT; Webster MJ; Kleinman JE; Freed WJ
Exp Neurol; 1998 Nov; 154(1):1-11. PubMed ID: 9875262
[TBL] [Abstract][Full Text] [Related]
39. Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes.
Ryan MM; Lockstone HE; Huffaker SJ; Wayland MT; Webster MJ; Bahn S
Mol Psychiatry; 2006 Oct; 11(10):965-78. PubMed ID: 16894394
[TBL] [Abstract][Full Text] [Related]
40. Investigation of unfolded-protein response in cells expressing familial Alzheimer's disease-linked presenilin variants.
Thinakaran G; Bowen JW; Ito D; Leem JY; Veselits ML; Sato N
Methods Mol Biol; 2003; 232():203-16. PubMed ID: 12840551
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
